Fundraising Fox
Psygen
3 known investors
Find your way into Psygen
Sign up to see every warm intro you have to Psygen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Psygen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use. The company serves researchers, physicians, and healthcare systems working within regulated compassionate-use and special access programs.
Founders & leadership
Investors · 3
Iter Investmentslisted by Iter InvestmentsSouth Florida
How we know: Iter Investments's portfolio page · Not right? Tell us
Eight CapitalreportedCaguas
How we know: funding news · press coverage · Not right? Tell us
In the news
Frequently asked questions
- What does Psygen do?
- Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use. The company serves researchers, physicians, and healthcare systems working within regulated compassionate-use and special access programs.
- Who founded Psygen?
- Psygen was founded by Danny Motyka, Peter van der Heyden.
- Who are Psygen's investors?
- Psygen's investors include Iter Investments, Noetic, Eight Capital.